What is "Drug News?" 

"Drug News" is a new resource offered by the JMSA to assist the layperson in managing the constantly changing landscape of pharmacology. It will provide the public with up-to-date information about common medications, including indications, contraindications, drug interactions, side effects, drug recalls, and the appearance of new drugs on the market. The goal is to help empower the patient in his or her own health care.

Institue for Safe Medical Practices "Do Not Crush List"

The Institue for Safe Medical Practices has identifed a list of oral medications which should not be crushed in order to ensure efficacy and prevent adverse events.

 www.ismp.org/Tools/DoNotCrush.pdf

Institute for Safe Medical Practice's High-Alert Medications List

The Institute for Safe Medical Practice has identified these medications as having a heightened risk of causing significant patient harm when they are used in error. 

http://www.ismp.org/Tools/highalertmedications.pdf

Pending and Recent Drug Approvals

Trivaris: The FDA has approved this injectable eye steroid suspension to  treat retinal disease.

Ustekinumab: An FDA panel voted to recommend approval for this injectable drug used to treat severe-to-moderate psoriasis. The FDA will vote on the drug by late September.